Patients of autoimmune diseases at high risk of developing apical periodontitis
Patients of autoimmune diseases at high risk of developing apical periodontitis suggests a new study published in the International Endodontic Journal
The prevalence of AP was 89.9% in AD patients and 74.2% in control subjects
The DMFT score was found to be significantly higher in the AD group
Patients with RA had the highest risk of being affected by AP, whereas those with IBD had the lowest risk. Multiple binary logistic regression analysis indicated that the teeth of AD patients who were not taking any medication or were being treated with biologic disease-modifying anti-rheumatic drugs (bDMARDs) had a higher risk of being affected by AP than did the teeth of the control subjects
The teeth of patients taking conventional DMARDs (cDMARDs) were less affected by AP compared with those of patients taking bDMARDs.
Patients with AD, whether treated or not with biologic medications, showed a higher prevalence of AP than did those in the control group. The DMFT index score, which was higher in AD patients compared with controls was identified as a significant predictor of AP prevalence.
Reference:
Allihaibi, M., Niazi, S.A., Farzadi, S., Austin, R., Ideo, F., Cotti, E. et al. (2023) Prevalence of apical periodontitis in patients with autoimmune diseases: A case-control study. International Endodontic Journal, 00, 1– 11. Available from: https://doi.org/10.1111/iej.13902
Keywords:
International Endodontic Journal, Patients, autoimmune, diseases, high risk, developing, apical periodontitis, Allihaibi, M., Niazi, S.A., Farzadi, S., Austin, R., Ideo, F., Cotti, E.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.